14.49MMarket Cap-0.10P/E (TTM)
4.5500High4.2200Low102.81KVolume4.4500Open4.3400Pre Close448.49KTurnover3.21%Turnover RatioLossP/E (Static)3.21MShares20.830052wk High1.20P/B14.45MFloat Cap1.800152wk Low--Dividend TTM3.20MShs Float1236.0000Historical High--Div YieldTTM7.60%Amplitude1.8000Historical Low4.3620Avg Price1Lot Size
Cingulate Stock Forum
📊⚡️📊
📊⚡️📊
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
Positive
Working capital increased by $19.5M from December 2023
Raised $12.5M in capital during Q3 2024
Net loss decreased by 46% YoY to $3.2M
R&D expenses reduced by $2.5M YoY
Secured European patents for CTx-1301 in up to 30 territories
Regained Nasdaq compliance with $1.00 minimum bid requirement
Negative
Accumulated deficit increa...
via @Lnova 👌
No comment yet